La chaîne d'options affiche les données clés des options sur actions de FrontView REIT à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour FrontView REIT..

FrontView REIT (NYSE:FVR) Stock, Chaîne d'Options

FrontView REIT

FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. The tenants of the company include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.

Cryptocurrency trading platform company Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) reported second-quarter financial results after <a href="https://www.benzinga.com/earnings">market close Thursday.</a>
Here are the highlights.
 What Happened: Coinbase reported second-quarter revenue of $1.5 billion, down 26% quarter-over-quarter. The revenue missed a Street consensus estimate of $1.69 billion, according to data<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0731"> from Benzinga Pro.</a>
Transaction revenue in the quarter was $764 million, down 39% quarter-over-quarter.
Subscription and services revenue was $656 million, down 6% quarter-over-quarter.
Trading volume was $237 billion in the quarter, down 40% quarter-over-quarter.
Transaction revenue was down year-over-year for both the consumer and institutional segments. The company said crypto spot volume was down 31% globally and 32% in the U.S. year-over-year.
The company ended the second quarter with $9.3 billion in USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) and $1.8 billion in crypto assets, which includes weekly Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) purchases.
Adjusted earnings per share of 12 cents missed the Street consensus estimate of $1.35.
Coinbase said its derivatives trading volume hit all-time highs in the quarter.
The company highlighted its growing USDC adoption, Base Chain going live in more places and scaling, the launch of Base APP in open beta with over 700,000 on the waitlist, and various cryptocurrency legislation pieces, including the GENIUS Act, signed into law.
"These bills provide a clear regulatory foundation for stablecoins and digital assets, potentially unlocking new opportunities for Coinbase and reinforcing U.S. leadership in digital finance," the company said.
Trading volume by cryptocurrency was:
<ul class="wp-block-list">
<li>Bitcoin: 30%</li>
<li>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>): 15%</li>
<li>Other: 55%</li>
</ul>
This compares to the first quarter, where Bitcoin was 27%, Ethereum was 11% and XRP Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) was 11%
Transaction revenue by cryptocurrency was:
<ul class="wp-block-list">
<li>Bitcoin: 34%</li>
<li>Ethereum: 12%</li>
<li>XRP:13%</li>
<li>Other: 41%</li>
</ul>
This compares to the first quarter when Bitcoin was 26%, Ethereum was 10%, Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) was 10% and XRP was 18%.
Read Also: <a href="https://www.benzinga.com/trading-ideas/previews/25/07/46742773/coinbase-q2-preview-can-white-house-momentum-bitcoin-all-time-highs-help">Coinbase Q2 Preview: Can White House Momentum, Bitcoin All-Time Highs Help?</a>
What's Next: Coinbase said it expects July transaction revenue to be $360 million.
The company is guiding for third-quarter subscription and services revenue to be in the range of $665 million to $745 million, surpassing the levels of the second quarter. The growth is attributed to higher cryptocurrency prices and stablecoin revenue.
Coinbase is guiding for higher expenses for the third quarter with higher headcount.
"The opportunities for growth have expanded substantially with increased regulatory clarity. We are taking this opportunity to grow headcount in exciting areas we expect to become meaningful in the future, including international expansion," the company said.
COIN Price Action: Coinbase stock is down 5.8% to $356.04 in after-hours trading Thursday versus a 52-week trading range of $142.58 to $444.64.
 Read Next: 
<ul class="wp-block-list">
<li>&nbsp;<a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46721901/jpmorgan-partners-with-coinbase-to-expand-crypto-access-for-80m-customers" target="_blank" rel="noreferrer noopener">JPMorgan Partners With Coinbase To Expand Crypto Access For 80M Customers</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Earnings

$BTC

$ETH

$SOL

$USDC

$XRP

COIN

Coinbase Q2 Earnings Highlights: Sales, EPS Miss, 40% Slide In Trading Volume

<a href="https://www.bloomberg.com/news/articles/2025-07-31/trump-asks-bank-ceos-to-pitch-on-fannie-freddie-stock-offerings" title="https://www.bloomberg.com/news/articles/2025-07-31/trump-asks-bank-ceos-to-pitch-on-fannie-freddie-stock-offerings">https://www.bloomberg.com/news/articles/2025-07-31/trump-asks-bank-ceos-to-pitch-on-fannie-freddie-stock-offerings</a>

News

FMCC

FNMA

'Trump Asks Bank CEOs to Pitch on Fannie, Freddie Stock Offerings' - Bloomberg News

Board Authorizes Purchase of Up to 3 Million Shares of Common Stock

Buybacks

AREN

The Arena Group Authorizes 3M Share Repurchase Program

- Purchases 4.9% of Great Elm Group's Common Stock; $150 Million Debt Investment in Monomoy Properties REIT to Accelerate Industrial Real Estate Platform Expansion –
- Company to Host Conference Call at 8:30 a.m. ET on August 1, 2025 -
Transaction Highlights:
<ul>
<li>Certain funds affiliated with Kennedy Lewis Investment Management LLC ("KLIM") purchase 4.9% of Great Elm Group, Inc's ("GEG") outstanding common stock at market price, approximately $2.11 per share.</li>
<li>$150 million of term loans in total strategic financing for Monomoy Properties REIT, LLC ("Monomoy REIT") from KLIM to catalyze growth across the Monomoy industrial real estate platform recently consolidated under Great Elm Real Estate Ventures, LLC ("Real Estate Ventures")</li>
<li>KLIM appoints board representatives at both GEG and Monomoy REIT, underscoring its commitment to a long-term partnership &nbsp;</li>
</ul>
PALM BEACH GARDENS, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- &nbsp;Great Elm Group, Inc. ("we," "us," "our," "GEG" or "Great Elm,") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEG#NASDAQ">GEG</a>), a publicly traded alternative asset manager, today announced a transformational strategic partnership with KLIM, an institutional alternative investment firm focused on opportunistic credit strategies including real estate with over $30 billion in assets under management. This partnership delivers up to $150 million in leverageable capital to support continued growth across Great Elm's real estate platform, which includes Monomoy REIT, Monomoy CRE (MCRE), Monomoy Construction Services (MCS), and Monomoy BTS (MBTS) (together "Monomoy"). Monomoy offers a full-service suite of project management, procurement, construction management, asset management, market analysis and feasibility services for its industrial real estate tenants.
Under the terms of the transaction, KLIM is providing an initial $100 million term loan to Monomoy REIT, and the option for an additional $50 million in future capital. Additionally, KLIM is purchasing 4.9% of GEG's common stock at market price, approximately $2.11 a share, and will hold an initial 15% profits interest (which may be increased to 20% under certain circumstances) in the newly formed Great Elm Real Estate Ventures, LLC, which consolidates GEG's real estate subsidiaries: MCRE, MCS, and MBTS.

Management

Kennedy Lewis Invests $150M In Monomoy REIT, Acquires 4.9% Stake In Great Elm Group To Accelerate Industrial Real Estate Growth

General

RKLB

Rocket Lab Opens Window For Its Next Mission For Multi-launch Customer, Institute For Q-shu Pioneers Of Space, Marking Electron's 69th Mission To Date And 11th Launch This Year

MODG

Topgolf Callaway Brands CEO Artie Starrs To Resign

<ul>
<li>Leqvio can now be used alone, without addition of statin therapy, as adjunct to diet and exercise for LDL-C reduction in patients with hypercholesterolemia (high LDL-C)1 &nbsp;</li>
<li>4 out of 5 atherosclerotic cardiovascular disease (ASCVD) patients do not reach guideline-recommended LDL-C target, reinforcing urgent need for more aggressive LDL-C lowering2-5 &nbsp;</li>
<li>Twice-yearly Leqvio is uniquely positioned to help support patient adherence and long-term LDL-C management, including goal attainment</li>
</ul>
Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio&#xAE; (inclisiran), enabling its use as monotherapy along with diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia1. The FDA proactively requested the label update based on the robust LDL-C lowering data for PCSK9-targeting therapies.
"This first-line label update reinforces Leqvio's proven ability to effectively lower LDL-C, a critical risk factor for heart disease," said Victor Bultó, President, US, Novartis. "With this new indication enabling Leqvio's use as monotherapy along with diet and exercise, we now have the potential to help even more patients achieve their LDL-C lowering goals earlier in their treatment journey."
With its twice-yearly, health care provider-administered dosing, Leqvio is uniquely positioned to help support patient adherence and long-term LDL-C management, including goal attainment. This is a critical unmet need, as up to 80% of ASCVD patients in the US struggle to reach the LDL-C guideline-recommended target of &lt;70 mg/dL2-5. This need is heightened by the latest 2025 ACC/AHA Joint Committee Clinical Practice Guideline for the Management of Patients with Acute Coronary Syndromes, which recommends more aggressive treatment to achieve LDL-C targets6.
The updated label removes the requirement for Leqvio to be used on top of or in combination with statin therapy1. Other updates include revising "primary hyperlipidemia" to the more specific term of "hypercholesterolemia" throughout the label, to more accurately focus on LDL-C reduction1.

Biotech

Novartis Announces That The U.S FDA  Has Approved A Label Update For Leqvio Allowing Its Use As Monotherapy Along With Diet And Exercise To Reduce Low-Density Lipoprotein Cholesterol In Adults With Hypercholesterolemia1.

Mirion Acquires Certrec For $81M

General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) has outperformed the market over the past 5 years by 1.76% on an annualized basis producing an average annual return of 15.63%. Currently, General Motors has a market capitalization of $50.78 billion. 
Buying $100 In GM: If an investor had bought $100 of GM stock 5 years ago, it would be worth $208.03 today based on a price of $53.34 for GM at the time of writing.
<h3>General Motors's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753994716_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In General Motors 5 Years Ago Would Be Worth This Much Today

YSXT

YSX TECH. CO. 2025 Total Revenue $71.5M, Up 22%

Natuzzi S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTZ#NYSE">NTZ</a>) ("Natuzzi" or the "Company") announced today that Mr. Antonio Achille, who has served as the Company's Chief Executive Officer and executive director since 2021, stepped down from his roles effective July 30, 2025, to pursue new professional opportunities.
Pending the appointment of a successor, the Board of Directors has temporarily delegated the CEO's powers and responsibilities to the Executive Chairman, Mr. Pasquale Natuzzi, who will serve in an interim capacity.

Natuzzi CEO Antonio Achille Resigns, Effective July 30, 2025; Board Temporarily Delegates CEO's Responsibilities To Executive Chairman, Pasquale Natuzzi

RBOT

Vicarious Surgical Appoints Stephen From As CEO

Azenta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZTA#NASDAQ">AZTA</a>) today announced that it has entered a collaboration with&nbsp;Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin genomic sequencing and data generation for Frenova's transformative MyReason&#xAE; genomics research program. This strategic collaboration aims to leverage cutting-edge technologies to enhance the understanding of cardio-kidney-metabolic diseases and drive advancements in precision medicine for patients worldwide.
The MyReason research program is an innovative initiative designed to uncover insights into the genetic mechanisms underlying kidney disease. To date, more than 35,000 participants have been registered in the program and provided biospecimens, with a goal of reaching 50,000 participants over the next two years.
Nephronomics holds exclusive commercial rights to the MyReason dataset, which anchors the Nephronomics Atlas, an unparalleled resource of deep clinical and genomic cardio-kidney-metabolic (CKM) disease data. Nephronomics aims to develop targeted therapies and redefine CKM disease care through precision medicine insights. By leveraging proprietary artificial intelligence (AI)/machine learning (ML) models trained on this comprehensive dataset, Nephronomics identifies novel disease subtypes, protective genetic variants, and therapeutic targets.
Azenta will support the collaboration by delivering genomic sequencing through GENEWIZ and managing long-term sample storage within its global biorepository network. With decades of experience in multiomics analysis and sample management solutions, Azenta is uniquely positioned to provide end-to-end solutions for complex research programs.

AZTA

Azenta Joins Frenova And Nephronomics To Power MyReason Genomics Program Aiming To Transform Precision CKM Disease Care

FBLG

FibroBiologics H1 2025 Net Loss ~$9.6M

BWXT

BWX Technologies Appoints Mike Fitzgerald As CFO

Gray Media has reached an agreement to acquire SagamoreHill Broadcasting's WLTZ, the NBC affiliate for the Columbus, Georgia, market (DMA 127), and KJTV, the FOX affiliate for the Lubbock, Texas, market (DMA 140). For the past several years, Gray has provided back-office services to both stations through its Columbus ABC affiliate WTVM and its Lubbock NBC affiliate KCBD, respectively.
Gray anticipates closing these transactions in the fourth quarter of this year following receipt of regulatory approval and other customary closing conditions. In that regard, Gray will request waivers of the FCC's current local broadcast ownership rule under the same "failing station" waiver standard through which the FCC has authorized similar combinations over the past 25 years, including earlier this year in connection with Gray's acquisition from SagamoreHill Broadcasting of KXLT, the FOX affiliated television station in the Rochester, Minnesota, market.

Gray Media Announces Agreement To Acquire SagamoreHill Broadcasting's Columbus , Georgia NBC Affiliate ALTZ And Lubbock, Texas Fox Affiliate KJTV, The Fox Affiliate For The Lubbock, Texas; Terms Not Disclosed

RARE

Ultragenyx Completes Enrollment In Its Phase 3 Aspire Study Of Apazunersen For Angelman Syndrome

Excelerate Energy, Inc. (the "Company" or "Excelerate") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EE#NYSE">EE</a>) announced today that its Board of Directors has declared a quarterly cash dividend, with respect to the quarter ended June 30, 2025, of $0.08 per share of Class A common stock, representing an approximately 33% increase from the prior quarter. The dividend is payable on September 4, 2025, to Class A common stockholders of record as of the close of business on August 20, 2025.

Dividends

Excelerate Energy Raises Quarterly Dividend By 33% From $0.06/Share To $0.08

FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), a leading global agricultural sciences company, today announced it has received registration for Fundatis&#xAE; herbicide powered by Isoflex&#xAE; active in Great Britain for use in winter wheat and winter barley. Isoflex&#xAE; active is a novel herbicide when used in cereals and is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide. Fundatis&#xAE; herbicide provides growers with a new tool to help manage herbicide resistance across a wide range of agronomic practices.

FMC Corp. Receives Registration For Fundatis Herbicide Powered By Isoflex Active In Great Britain For Use In Winter Wheat And Winter Barley

INCY

Knight Therapeutics Submitted Supplemental Application To ANVISA For Approval Of Additional Indication For MINJUVI

Press Releases

Modiv Industrial Announces Latest Portfolio Appraisal

FrontView REIT Announces January/February Investment Activity and Attendance of Citi's 30th Annual Global Property CEO Conference March 2-4

FrontView REIT Fixes $200 Million Term-Loan to Mitigate Interest Rate Volatility

FrontView REIT Announces Fourth Quarter and Full Year 2024 Results and Initiates 2025 Guidance

FrontView REIT Announces First Quarter 2025 Earnings Release Date and Conference Call Information

FrontView REIT Announces Q1/25 Investment Activity, the appointment of Randall Starr as CFO, and an Operational and Tenant Update

FrontView REIT Announces First Quarter 2025 Results and Updates Full Year 2025 Guidance

FrontView REIT Announces Appointment of Sean Fukumura as Interim CFO

FrontView REIT Appoints Pierre Revol, Seasoned Industry Executive, as Chief Financial Officer

FrontView REIT Announces Second Quarter 2025 Earnings Release Date and Conference Call Information

GOOD

LAND

NLOP

PINE

PLYM

TSLA

Agree Realty

Acadia Realty Trust

Alexander's

Saul Centers

Brixmor Property Group

CBL & Associates Properties, Inc. Common Stock

CBL & Associates

Curbline Properties

Federal Realty Investment Trust Common Stock

Federal Realty Investment

Getty Realty

InvenTrust Properties

Kimco Realty Corporation (HC) Common Stock

Kimco Realty

Kite Realty Gr Trust

Macerich

NNN REIT

Netstreit

Realty Income

Phillips Edison & Company, Inc. - Common Stock

Phillips Edison & Co

Regency Centers Corporation - Common Stock

Regency Centers

Regency Centers Corporation - 5.875% Series B Cumulative Redeemable Preferred Stock

SITE Centers

Tanger

Simon Property Group

Urban Edge Properties Common Shares of Beneficial Interest

Urban Edge Props

Wheeler Real Estate Investment Trust, Inc. - Series D Cumulative Preferred Stock

Comments

FrontView REIT

FrontView REIT (FVR) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL